Clinical Trial Update: A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating CK-2127107 on physical function in adults with chronic obstructive pulmonary disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CK-2127107

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED | Results posted: 2021-02-05